Microbiota Modulation in Oncology: Implications For Cancer Development And Therapeutic Strategies

Abstract

In oncology, microbiota balance studies the complex relationship between the body’s microbial networks and cancerous development. The billions of microbes that comprise the human microbiota are essential for maintaining homeostasis and affecting a number of physiological functions. Recent research suggests that modifications to this microbial ecosystem may have an impact on the onset and course of cancer. An imbalance in the microbiota known as dysbiosis has been linked to irritability, safe brokenness, and—surprisingly—direct effects on carcinogenesis. Comprehending the relationships between microbiota and malignant growth facilitates the development of innovative restorative techniques. Analysts are investigating the potential implications of targeted microbiota modification for malignant growth therapy outcomes. It is becoming evident that probiotics, prebiotics, and fecal microbiota transplantation may be utilized to improve the efficacy of traditional cancer therapies by reestablishing the microbial balance. Moreover, there is a growing body of research on the influence of the microbiome on immunotherapy responses. All things considered, deciphering the astounding relationship between microbiota and cancerous development promises to advance our understanding of the causes of disease and improve treatment approaches. In this review, the part microbiota plays in carcinogenesis, how microbiota can lead to cancer and different therapeutic strategies such as diet, probiotics, phytochemical and so on were discussed.